CT IND GROUP (08111) requests the GEM Listing Review Committee of the Hong Kong Stock Exchange to review the suspension decision.

16:48 07/01/2026

China Technology Industry Group (08111) announced that, following professional advice, the Company submitted a written request on 7th January 2026 to seek review by the Listing Review Committee of the GEM of the Stock Exchange in accordance with Chapter 4 of the GEM Listing Rules. Therefore, trading of the Company's shares will continue. If there are any significant developments in the above matter, the Company will make further announcements in accordance with the requirements of the GEM Listing Rules at the appropriate time.

CT IND GROUP (08111) announced that, after seeking professional advice, the company submitted a written request on January 7, 2026, to the Listing Review Committee of the Stock Exchange of Hong Kong Limited (GEM) for a review of the decision pursuant to Chapter 4 of the GEM Listing Rules. Therefore, trading of the company's shares will continue. If there are any significant developments on the matter, the company will issue further announcements in accordance with the requirements of the GEM Listing Rules at the appropriate time.

On January 8th, Dingdang Health (09886) spent HK $1.5677 million to repurchase 1.42 million shares.

CHAOJU EYE CARE (02219) spent 160,700 Hong Kong dollars on January 8 to repurchase 60,000 shares.

Blue Moon Group (06993): Use the minimum specified public shareholding level as a substitute for the threshold.

On January 8th, Dingdang Health (09886) spent HK $1.5677 million to repurchase 1.42 million shares.

CHAOJU EYE CARE (02219) spent 160,700 Hong Kong dollars on January 8 to repurchase 60,000 shares.

Blue Moon Group (06993): Use the minimum specified public shareholding level as a substitute for the threshold.